Eosinophil granule proteins and their role in disease

Current Opinion in Hematology

Volumn 8, Issue 1, 2001, Pages 28-33

  Walsh, Garry M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MAJOR BASIC PROTEIN;

ALLERGIC DISEASE; ASTHMA; CYTOTOXICITY; EOSINOPHIL; GRANULE CELL; HELMINTHIASIS; IMMUNE RESPONSE; INFECTION; INFLAMMATION; MEDIATOR RELEASE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; TISSUE INJURY;

BLOOD PROTEINS; CELL DEGRANULATION; CYTOPLASMIC GRANULES; EOSINOPHILS; HUMANS; INFLAMMATION;

EID: 0035174635     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200101000-00006     Document Type: Review

References (45)

1. Do eosinophils have a role in the killing of helminth parasites?
2. Advances in the immunobiology of eosinophils and their role in disease
3. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, atopic eczema
4. Mechanisms of eosinophil-associated inflammation
5. Eosinophils: Structure and functions
6. Human eosinophil granule proteins: Structure, function and release
7. A novel and highly divergent homolog of human eosinophil granule major basic protein
8. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein
9. Eosinophils generate brominating oxidants in allergen-induced asthma
10. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders
11. Increased amounts of nitric oxide in exhaled air of asthmatics
12. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid
13. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins
14. Localisation of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes
15. New aspects of degranulation and fates of airway mucosal eosinophils
16. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways
17. Exocytotic events in eosinophils and mast cells
18. Eosinophil apoptosis: Mechanisms and clinical relevance in asthmatic and allergic inflammation
19. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils
20. Does IgE bind to and activate eosinophils from patients with allergy?
21. Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function
22. Eotaxin and eosinophil recruitment: Implications for human disease
23. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases
24. Rapid mobilization of intracellularly stored RANTES in response to interferon-γ in human eosinophils
25. Intracellular location of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon-γ
26. Immunofluorescence analysis of cytokine and granule protein expression during eosinophil maturation from cord blood-derived CD34 + progenitors
27. Inflammation in asthma: The cornerstone of the disease and target of therapy
28. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm
29. Eosinophil cationic protein (ECP): Molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease
30. Cationic proteins and bronchial hyperresponsiveness
31. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung
32. Antigen-induced hyperreactivity to histamine: Role of the vagus nerves and eosinophils
33. Eosinophils as a source of matrix mellatoprotease 9 in asthmatic airway inflammation
34. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-α
35. Migration of eosinophils through basement membrane components in vitro: Role of metalloproteinase-9
36. Inhibition of matrix mellatoproteinases prevents allergen-induced airway inflammation in a murine model of asthma
37. Community study of the role of viral infections in exacerbation of asthma in 9-11 year old children
38. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial infection
39. CD8 T cells are essential in the development of respiratory syncytial virus-induce lung eosinophilia and airway hyperresponsiveness
40. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus
41. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism
42. Respiratory syncytical virus-induced chemokine expression in the lower airways. Eosinophil recruitment and degranulation
43. RANTES, macrophage inhibitory protein 1α and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children
44. Eosinophil cationic protein RNase 3 is another RNaseA-family ribonuclease with direct antiviral activity
45. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus